non-autoimmune disorders (chronic liver disease other than primary biliary cirrhosis 11, non-hepatic diseases 17), and 16 healthy subjects. Of the 122 patients, 108 were women and 14 were men. The average age was 52 years with a range of 17 Definite keratoconjunctivitis sicca occurred in 24% of patients with rheumatoid arthritis, in 19% of patients with scleroderma, in 50% of patients with primary biliary cirrhosis, in 10% of patients with other autoimmune diseases, in 10% of patients with chronic liver disease other than primary biliary cirrhosis, and in 6% of patients with non-hepatic diseases and healthy subjects. Definite keratoconjunctivitis sicca was found in 35% of patients with autoimmune diseases and in 5% of those with other disorders.
ORAL COMPONENT
Definite xerostomia occurred in 52% of patients with rheumatoid arthritis, in 69% of patients with scleroderma, in 58% of patients with primary biliary cirrhosis, in 36% of patients with other autoimmune diseases, in 9% of patients with chronic liver disease other than primary biliary cirrhosis, and in 3% of patients with non-hepatic diseases and healthy subjects. Definite xerostomia was present in 67% of patients with autoimmune diseases and in 4% of those with other disorders. SJOGREN'S SYNDROME Fig. 1 shows the prevalence of definite Sjogren's syndrome in association with a variety of pathological conditions; it occurred in 62% of patients with rheumatoid arthritis, in 69% of patients with scleroderma, in 71% of patients with primary biliary cirrhosis, and in 36% of patients with other autoimmune diseases. Sjogren's syndrome was not present in any of the patients with chronic liver disease other than primary biliary cirrhosis, in any of the patients with non-hepatic disorders, or in any of the healthy subjects. Definite Sjogren's syndrome was found in 61% of patients with autoimmune diseases and in none of the patients with non-autoimmune conditions.
Definite or probable Sjogren's syndrome occurred in 86% ofpatients with rheumatoid arthritis, in 88% of patients with scleroderma, in all patients with primary biliary cirrhosis, and in 82% of patients with other autoimmune diseases. Nine per cent of patients with chronic liver disease other than primary biliary cirrhosis and 6% of patients with nonhepatic diseases and healthy subjects had probable Sjogren autoimmune diseases and in only 6% of patients with other diseases. Forty nine of the 122 patients included in the study had a definite Sjogren's syndrome, and 77 had the syndrome definitely or probably. Of these 49 patients, 13 (26%) had rheumatoid arthritis, 11 (22%) had scleroderma, 11 (22%) had sicca syndrome alone, 10 (20%) had primary biliary cirrhosis, one had systemic lupus erythematosus, one had dermatomyositis, one had idiopathic pulmonary fibrosis, and one had Hasimoto's thyroiditis. All these 49 patients were women except for one man who had rheumatoid arthritis. Of the 77 patients with definite or probable Sjogren's syndrome, 18 (23%) had rheumatoid arthritis, 17 
